CHG: Pivot Focus to Organic Growth in 2022
Upgrade to BUY with a TP of Bt3.9, based on 30xPE’22E, which is its pre-COVID bottom level. The 27% drop in share price from Jul 21 peak priced in...
271 Views
Rajthanee Hospital (RJH TB): Q4 Revenue Growth to Decelerate Sequentially as Covid Tailwind Fades
Q4 revenue is expected to slow down q/q as new Covid-19 cases in Thailand is declining steadily. However, non-covid business is recovering. The...
282 Views
CHG: Expect 4Q21 Earnings to Soften QoQ
Yesterdays’ analyst meeting came out with a neutral tone. We expect 4Q21 margins to decline, in-response to rollover from exceptionally high 3Q21...
278 Views
CHG: Even Stronger in 3Q21E
We upgrade our recommendation to BUY rating, from HOLD, with 2022E target price of Bt4.36, derived from 38.6x PE, which is its 3-year trading average.
219 Views
CHG: Covid Windfall Boosted 2Q21 Performance
We maintain HOLD rating with 2022E target price of Bt4.36, +28% from Bt3.40 previously, derived from 38.6x PE, which is its 3-year trading average.
190 Views